Literature DB >> 33362788

The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology.

Andrina Rutsch1, Johan B Kantsjö1, Francesca Ronchi1.   

Abstract

The human microbiota has a fundamental role in host physiology and pathology. Gut microbial alteration, also known as dysbiosis, is a condition associated not only with gastrointestinal disorders but also with diseases affecting other distal organs. Recently it became evident that the intestinal bacteria can affect the central nervous system (CNS) physiology and inflammation. The nervous system and the gastrointestinal tract are communicating through a bidirectional network of signaling pathways called the gut-brain axis, which consists of multiple connections, including the vagus nerve, the immune system, and bacterial metabolites and products. During dysbiosis, these pathways are dysregulated and associated with altered permeability of the blood-brain barrier (BBB) and neuroinflammation. However, numerous mechanisms behind the impact of the gut microbiota in neuro-development and -pathogenesis remain poorly understood. There are several immune pathways involved in CNS homeostasis and inflammation. Among those, the inflammasome pathway has been linked to neuroinflammatory conditions such as multiple sclerosis, Alzheimer's and Parkinson's diseases, but also anxiety and depressive-like disorders. The inflammasome complex assembles upon cell activation due to exposure to microbes, danger signals, or stress and lead to the production of pro-inflammatory cytokines (interleukin-1β and interleukin-18) and to pyroptosis. Evidences suggest that there is a reciprocal influence of microbiota and inflammasome activation in the brain. However, how this influence is precisely working is yet to be discovered. Herein, we discuss the status of the knowledge and the open questions in the field focusing on the function of intestinal microbial metabolites or products on CNS cells during healthy and inflammatory conditions, such as multiple sclerosis, Alzheimer's and Parkinson's diseases, and also neuropsychiatric disorders. In particular, we focus on the innate inflammasome pathway as immune mechanism that can be involved in several of these conditions, upon exposure to certain microbes.
Copyright © 2020 Rutsch, Kantsjö and Ronchi.

Entities:  

Keywords:  Alzheimer’s disease; Parkinson’s disease; gut-brain axis; inflammasome; microbiota; multiple sclerosis; neuropsychiatric disorders

Mesh:

Substances:

Year:  2020        PMID: 33362788      PMCID: PMC7758428          DOI: 10.3389/fimmu.2020.604179

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  248 in total

1.  The NLR Protein NLRP6 Does Not Impact Gut Microbiota Composition.

Authors:  Paul Lemire; Susan J Robertson; Heather Maughan; Ivan Tattoli; Catherine J Streutker; Jaye M Platnich; Daniel A Muruve; Dana J Philpott; Stephen E Girardin
Journal:  Cell Rep       Date:  2017-12-26       Impact factor: 9.423

2.  Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10.

Authors:  Olga L Rojas; Anne-Katrin Pröbstel; Elisa A Porfilio; Angela A Wang; Marc Charabati; Tian Sun; Dennis S W Lee; Georgina Galicia; Valeria Ramaglia; Lesley A Ward; Leslie Y T Leung; Ghazal Najafi; Khashayar Khaleghi; Beatriz Garcillán; Angela Li; Rickvinder Besla; Ikbel Naouar; Eric Y Cao; Pailin Chiaranunt; Kyle Burrows; Hannah G Robinson; Jessica R Allanach; Jennifer Yam; Helen Luck; Daniel J Campbell; David Allman; David G Brooks; Michio Tomura; Ryan Baumann; Scott S Zamvil; Amit Bar-Or; Marc S Horwitz; Daniel A Winer; Arthur Mortha; Fabienne Mackay; Alexandre Prat; Lisa C Osborne; Clinton Robbins; Sergio E Baranzini; Jennifer L Gommerman
Journal:  Cell       Date:  2019-01-03       Impact factor: 41.582

3.  Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia.

Authors:  Changyoun Kim; Dong-Hwan Ho; Ji-Eun Suk; Sungyong You; Sarah Michael; Junghee Kang; Sung Joong Lee; Eliezer Masliah; Daehee Hwang; He-Jin Lee; Seung-Jae Lee
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

4.  Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring.

Authors:  Shelly A Buffington; Gonzalo Viana Di Prisco; Thomas A Auchtung; Nadim J Ajami; Joseph F Petrosino; Mauro Costa-Mattioli
Journal:  Cell       Date:  2016-06-16       Impact factor: 41.582

5.  Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice.

Authors:  C Dempsey; A Rubio Araiz; K J Bryson; O Finucane; C Larkin; E L Mills; A A B Robertson; M A Cooper; L A J O'Neill; M A Lynch
Journal:  Brain Behav Immun       Date:  2016-12-18       Impact factor: 7.217

6.  Gut microbiome alterations in Alzheimer's disease.

Authors:  Nicholas M Vogt; Robert L Kerby; Kimberly A Dill-McFarland; Sandra J Harding; Andrew P Merluzzi; Sterling C Johnson; Cynthia M Carlsson; Sanjay Asthana; Henrik Zetterberg; Kaj Blennow; Barbara B Bendlin; Federico E Rey
Journal:  Sci Rep       Date:  2017-10-19       Impact factor: 4.379

7.  Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression.

Authors:  Xinyi Wang; Guangqiang Sun; Teng Feng; Jing Zhang; Xun Huang; Tao Wang; Zuoquan Xie; Xingkun Chu; Jun Yang; Huan Wang; Shuaishuai Chang; Yanxue Gong; Lingfei Ruan; Guanqun Zhang; Siyuan Yan; Wen Lian; Chen Du; Dabing Yang; Qingli Zhang; Feifei Lin; Jia Liu; Haiyan Zhang; Changrong Ge; Shifu Xiao; Jian Ding; Meiyu Geng
Journal:  Cell Res       Date:  2019-09-06       Impact factor: 25.617

8.  Prefrontal cortex infusion of beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produces antidepressant-like effects in a rodent model of depression.

Authors:  Naofumi Kajitani; Masaaki Iwata; Akihiko Miura; Kyohei Tsunetomi; Takehiko Yamanashi; Ryoichi Matsuo; Tsuyoshi Nishiguchi; Saki Fukuda; Mayu Nagata; Midori Shibushita; Takahira Yamauchi; Shenghong Pu; Yukihiko Shirayama; Ken Watanabe; Koichi Kaneko
Journal:  Neuropsychopharmacol Rep       Date:  2020-03-03

9.  Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.

Authors:  Gaia Codolo; Nicoletta Plotegher; Tommaso Pozzobon; Marco Brucale; Isabella Tessari; Luigi Bubacco; Marina de Bernard
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

10.  Host microbiota modulates development of social preference in mice.

Authors:  Tim Arentsen; Henrike Raith; Yu Qian; Hans Forssberg; Rochellys Diaz Heijtz
Journal:  Microb Ecol Health Dis       Date:  2015-12-15
View more
  64 in total

Review 1.  Unravelling the potential of gut microbiota in sustaining brain health and their current prospective towards development of neurotherapeutics.

Authors:  Ankita Banerjee; Lilesh Kumar Pradhan; Santosh Chauhan; Pradyumna Kumar Sahoo; Kautilya Kumar Jena; Nishant Ranjan Chauhan; Saroj Kumar Das
Journal:  Arch Microbiol       Date:  2021-03-24       Impact factor: 2.552

2.  Inflammasome-Regulated Pyroptotic Cell Death in Disruption of the Gut-Brain Axis After Stroke.

Authors:  Nadine A Kerr; Juliana Sanchez; Gregory O'Connor; Brant D Watson; Sylvia Daunert; Helen M Bramlett; W Dalton Dietrich
Journal:  Transl Stroke Res       Date:  2022-03-19       Impact factor: 6.829

3.  Therapeutic Effect of Buyang Huanwu Decoction on the Gut Microbiota and Hippocampal Metabolism in a Rat Model of Cerebral Ischemia.

Authors:  Rongmei Tang; Jian Yi; Shuangying Lu; Bowei Chen; Baiyan Liu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-14       Impact factor: 6.073

Review 4.  The Pathological Mechanism Between the Intestine and Brain in the Early Stage of Parkinson's Disease.

Authors:  Runing Yang; Ge Gao; Hui Yang
Journal:  Front Aging Neurosci       Date:  2022-06-24       Impact factor: 5.702

5.  Minocycline Reduces Hypothalamic Microglia Activation and Improves Metabolic Dysfunction in High Fat Diet-Induced Obese Mice.

Authors:  Caitlin R Coker; Melissa White; Aneesh Singal; Sarah S Bingaman; Anirban Paul; Amy C Arnold; Yuval Silberman
Journal:  Front Physiol       Date:  2022-06-16       Impact factor: 4.755

Review 6.  TREGking From Gut to Brain: The Control of Regulatory T Cells Along the Gut-Brain Axis.

Authors:  Juli Choi; Bo-Ram Kim; Begum Akuzum; Leechung Chang; June-Yong Lee; Ho-Keun Kwon
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

7.  Detection of Dysbiosis and Increased Intestinal Permeability in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis.

Authors:  Felipe Papa Pellizoni; Aline Zazeri Leite; Nathália de Campos Rodrigues; Marcelo Jordão Ubaiz; Marina Ignácio Gonzaga; Nauyta Naomi Campos Takaoka; Vânia Sammartino Mariano; Wellington Pine Omori; Daniel Guariz Pinheiro; Euclides Matheucci Junior; Eleni Gomes; Gislane Lelis Vilela de Oliveira
Journal:  Int J Environ Res Public Health       Date:  2021-04-27       Impact factor: 3.390

8.  Supplementation of Lactobacillus early in life alters attention bias to threat in piglets.

Authors:  Else Verbeek; Johan Dicksved; Linda Keeling
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

Review 9.  The interaction of Akkermansia muciniphila with host-derived substances, bacteria and diets.

Authors:  Tatsuro Hagi; Clara Belzer
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-14       Impact factor: 4.813

10.  Influence of a High-Impact Multidimensional Rehabilitation Program on the Gut Microbiota of Patients with Multiple Sclerosis.

Authors:  Monica Barone; Laura Mendozzi; Federica D'Amico; Marina Saresella; Simone Rampelli; Federica Piancone; Francesca La Rosa; Ivana Marventano; Mario Clerici; Alessia d'Arma; Luigi Pugnetti; Valentina Rossi; Marco Candela; Patrizia Brigidi; Silvia Turroni
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.